CYP2D6 genotypes in a Japanese population:: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10

被引:110
作者
Nishida, Y [1 ]
Fukuda, T [1 ]
Yamamoto, I [1 ]
Azuma, J [1 ]
机构
[1] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan
来源
PHARMACOGENETICS | 2000年 / 10卷 / 06期
关键词
CYP2D6; frequency; gene duplication; CYP2D6*10; Japanese;
D O I
10.1097/00008571-200008000-00010
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:567 / 570
页数:4
相关论文
共 18 条
[1]   GENETIC-BASIS FOR DIFFERENCES IN DEBRISOQUIN POLYMORPHISM BETWEEN A SPANISH AND OTHER WHITE-POPULATIONS [J].
AGUNDEZ, JAG ;
MARTINEZ, C ;
LEDESMA, MC ;
LADONA, MG ;
LADERO, JM ;
BENITEZ, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (04) :412-417
[2]   PREVALENCE OF CYP2D6 GENE DUPLICATION AND ITS REPERCUSSION ON THE OXIDATIVE PHENOTYPE IN A WHITE-POPULATION [J].
AGUNDEZ, JAG ;
LEDESMA, MC ;
LADERO, JM ;
BENITEZ, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (03) :265-269
[3]  
Aklillu E, 1996, J PHARMACOL EXP THER, V278, P441
[4]   DEBRISOQUINE SPARTEINE HYDROXYLATION GENOTYPE AND PHENOTYPE - ANALYSIS OF COMMON MUTATIONS AND ALLELES OF CYP2D6 IN A EUROPEAN POPULATION [J].
BROLY, F ;
GAEDIGK, A ;
HEIM, M ;
EICHELBAUM, M ;
MORIKE, K ;
MEYER, UA .
DNA AND CELL BIOLOGY, 1991, 10 (08) :545-558
[5]   THE ROLE OF INDIVIDUAL HUMAN CYTOCHROMES-P450 IN DRUG-METABOLISM AND CLINICAL-RESPONSE [J].
CHOLERTON, S ;
DALY, AK ;
IDLE, JR .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (12) :434-439
[6]   GENETIC-ANALYSIS OF THE CYP2D LOCUS IN RELATION TO DEBRISOQUINE HYDROXYLATION CAPACITY IN KOREAN, JAPANESE AND CHINESE SUBJECTS [J].
DAHL, ML ;
YUE, QY ;
ROH, HK ;
JOHANSSON, I ;
SAWE, J ;
SJOQVIST, F ;
BERTILSSON, L .
PHARMACOGENETICS, 1995, 5 (03) :159-164
[7]  
DAHL ML, 1995, J PHARMACOL EXP THER, V274, P516
[8]   Effect of the CYP2D6*10 genotype on venlafaxine pharmacokinetics in healthy adult volunteers [J].
Fukuda, T ;
Yamamoto, I ;
Nishida, Y ;
Zhou, Q ;
Ohno, M ;
Takada, K ;
Azuma, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (04) :450-453
[9]   Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population [J].
Griese, EU ;
Zanger, UM ;
Brudermanns, U ;
Gaedigk, A ;
Mikus, G ;
Morike, K ;
Stuven, T ;
Eichelbaum, M .
PHARMACOGENETICS, 1998, 8 (01) :15-26
[10]   GENOTYPING OF POOR METABOLIZERS OF DEBRISOQUINE BY ALLELE-SPECIFIC PCR AMPLIFICATION [J].
HEIM, M ;
MEYER, UA .
LANCET, 1990, 336 (8714) :529-532